{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T19:38:07Z","timestamp":1726429087641},"reference-count":125,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tierarztl Prax Ausg K Kleintiere Heimtiere"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Die Impfung ist die wichtigste Ma\u00dfnahme zum Schutz vor kaniner Parvovirose. Daher z\u00e4hlt die Impfung gegen das kanine Parvovirus (CPV) zu den Core-Komponenten der Hundeimpfung. Modifizierte Lebendvakzinen (MLV) haben sich als sehr wirksam und zugleich sicher erwiesen. Sie bieten einen zuverl\u00e4ssigen Schutz, der bereits nach wenigen Tagen eintritt und viele Jahre anh\u00e4lt. MLV enthalten keine Adjuvanzien; sie sind hinsichtlich ihres allergenen und toxischen Potenzials Impfstoffen mit inaktiviertem CPV in aller Regel \u00fcberlegen. Aus diesen Gr\u00fcnden werden MLV Impfstoffen aus inaktivierten Viren vorgezogen. In Deutschland und in den meisten anderen L\u00e4ndern Europas sind heute ausschlie\u00dflich MLV auf dem Markt verf\u00fcgbar. Sie enthalten attenuiertes CPV-2 oder (seltener) CPV-2b und bieten einen kreuzprotektiven Schutz gegen die f\u00fcr den Hund im Feld relevanten Varianten CPV-2a, -2b, -2c. Wiederholungsimpfungen bei adulten Hunden mit MLV sollten fr\u00fchestens alle 3 Jahre oder in l\u00e4ngeren Intervallen (nach Bedarf bei fehlenden Antik\u00f6rpern) durchgef\u00fchrt werden. Dies gilt selbst dann, wenn der verwendete Impfstoff nur f\u00fcr eine 1- oder 2-Jahres-Intervall zugelassen ist. MLV-Produkte werden zur Impfung gesunder Hunde ab der 4. bis 6. Lebenswoche empfohlen. Ein Nachteil von MLV besteht in einer potenziellen Interferenz mit der Parvovirosediagnostik.<\/jats:p>","DOI":"10.1055\/a-1402-9476","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T22:42:13Z","timestamp":1619476933000},"page":"122-125","source":"Crossref","is-referenced-by-count":1,"title":["Prophylaxe der kaninen Parvovirose"],"prefix":"10.1055","volume":"49","author":[{"given":"Mich\u00e8le","family":"Bergmann","sequence":"additional","affiliation":[{"name":"Medizinische Kleintierklinik, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Freisl","sequence":"additional","affiliation":[{"name":"Medizinische Kleintierklinik, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Medizinische Kleintierklinik, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"key":"ref1","first-page":"233","article-title":"Current and future canine and feline vaccination programs","volume":"93","author":"R D Schultz","year":"1998","journal-title":"Vet Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/jsap.2_12431","article-title":"WSAVA Guidelines for the vaccination of dogs and cats","volume":"57","author":"M J Day","year":"2016","journal-title":"J Small Anim Pract"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5326\/jaaha-ms-6741","article-title":"2017 AAHA Canine Vaccination Guidelines","volume":"53","author":"R B Ford","year":"2017","journal-title":"J Am Anim Hosp Assoc"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/tbed.13022","article-title":"The geographic distribution and financial impact of canine parvovirus in Australia","volume":"66","author":"M Kelman","year":"2019","journal-title":"Transbound Emerg Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5326\/0400349","article-title":"Report of the American Animal Hospital Association (AAHA) Canine Vaccine Task Force: executive summary and 2003 canine vaccine guidelines and recommendations","volume":"39","author":"M A Paul","year":"2003","journal-title":"J Am Anim Hosp Assoc"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5326\/0420080","article-title":"2006 AAHA canine vaccine guidelines","volume":"42","author":"M A Paul","year":"2006","journal-title":"J Am Anim Hosp Assoc"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5326\/jaaha-ms-4000","article-title":"2011 AAHA canine vaccination guidelines","volume":"47","author":"L V Welborn","year":"2011","journal-title":"J Am Anim Hosp Assoc"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.jcpa.2007.04.005","article-title":"Immune system development in the dog and cat","volume":"137","author":"M J Day","year":"2007","journal-title":"J Comp Pathol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1751-0813.1979.tb15259.x","article-title":"Isolation from dogs with severe enteritis of a parvovirus related to feline panleukopenia virus","volume":"55","author":"R Johnson","year":"2008","journal-title":"Aust Vet J"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1051\/vetres\/2010011","article-title":"The emergence of parvoviruses of carnivores","volume":"41","author":"K Hoelzer","year":"2010","journal-title":"Vet Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetmic.2011.09.007","article-title":"Canine parvovirus \u2013 a review of epidemiological and diagnostic aspects, with emphasis on type 2c","volume":"155","author":"N Decaro","year":"2012","journal-title":"Vet Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.vetmic.2011.12.024","article-title":"Canine parvovirus in asymptomatic feline carriers","volume":"157","author":"S R Clegg","year":"2012","journal-title":"Vet Microbiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1128\/JVI.65.12.6544-6552.1991","article-title":"Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus","volume":"65","author":"C R Parrish","year":"1991","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1126\/science.4059921","article-title":"Natural variation of canine parvovirus","volume":"230","author":"C R Parrish","year":"1985","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1099\/0022-1317-82-12-3021","article-title":"Evidence for evolution of canine parvovirus type 2 in Italy","volume":"82","author":"C Buonavoglia","year":"2001","journal-title":"J Gen Virol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tvjl.2017.01.020","article-title":"Canine parvovirus post-vaccination shedding: Interference with diagnostic assays and correlation with host immune status","volume":"221","author":"N Decaro","year":"2017","journal-title":"Vet J"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetmic.2015.07.027","article-title":"Are licensed canine parvovirus (CPV2 and CPV2b) vaccines able to elicit protection against CPV2c subtype in puppies?: A systematic review of controlled clinical trials","volume":"180","author":"B Hern\u00e1ndez-Blanco","year":"2015","journal-title":"Vet Microbiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1128\/jcm.01300-07","article-title":"Canine parvovirus types 2c and 2b circulating in North American dogs in 2006 and 2007","volume":"45","author":"S Kapil","year":"2007","journal-title":"J Clin Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cvsm.2008.03.008","article-title":"Parvovirus infection in domestic companion animals","volume":"38","author":"C G Lamm","year":"2008","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.vetmic.2012.02.034","article-title":"Risk factors for death from canine parvoviral-related disease in Australia","volume":"158","author":"M Ling","year":"2012","journal-title":"Vet Microbiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.5829\/idosi.wasj.2013.23.10.1823","article-title":"Emergence of canine parvovirus \u2013 2 variants and its impact on vaccination","volume":"23","author":"S Nandi","year":"2013","journal-title":"World Appl Sci J"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.vaccine.2008.11.027","article-title":"Review of companion animal viral diseases and immunoprophylaxis","volume":"27","author":"J R Patel","year":"2009","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.vetmic.2006.04.003","article-title":"Evolution of canine parvovirus \u2013 a need for new vaccines?","volume":"117","author":"U Truyen","year":"2006","journal-title":"Vet Microbiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1128\/cvi.00444-07","article-title":"Evaluation of the antigenic relationships among canine parvovirus type 2 variants","volume":"15","author":"A Cavalli","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11262-007-0189-6","article-title":"Prevalence and genetic characterization of canine parvoviruses in Korea","volume":"36","author":"B K Kang","year":"2008","journal-title":"Virus Genes"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1292\/jvms.70.769","article-title":"Chronological analysis of canine parvovirus type 2 isolates in Japan","volume":"70","author":"T Ohshima","year":"2008","journal-title":"J Vet Med Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1128\/cdli.8.3.612-615.2001","article-title":"Canine parvovirus (CPV) vaccination: Comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine","volume":"8","author":"A Pratelli","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref33","first-page":"1091","article-title":"Can a commercial vaccine protect pups against a recent field isolate of parvovirus?","volume":"82","author":"M JG Appel","year":"1987","journal-title":"Vet Med"},{"key":"ref34","first-page":"217","article-title":"Canine parvovirus (CPV) type 2b vaccine protects puppies with maternal antibodies to CPV when challenged with virulent CPV-2c virus","volume":"10","author":"S Glover","year":"2012","journal-title":"Int J Appl Res Vet Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/vr.136.3.63","article-title":"Comparison of isolates of canine parvovirus by restriction enzyme analysis, and vaccine efficacy against field strains","volume":"136","author":"N M Greenwood","year":"1995","journal-title":"Vet Rec"},{"key":"ref36","first-page":"94","article-title":"Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant?","volume":"9","author":"L J Larson","year":"2008","journal-title":"Vet Ther"},{"key":"ref37","first-page":"58","article-title":"Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c","volume":"124","author":"E M Siedek","year":"2011","journal-title":"Berl Munch Tierarztl Wochenschr"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.vetmic.2007.09.015","article-title":"Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus","volume":"128","author":"N Spibey","year":"2008","journal-title":"Vet Microbiol"},{"key":"ref39","first-page":"187","article-title":"Cross protection of vanguard 5L4-CV vaccine against virulent canine parvovirus-2c circulating in the USA","volume":"10","author":"M Von Reitzenstein","year":"2012","journal-title":"Int J Appl Res Vet M"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1016\/j.vaccine.2014.07.102","article-title":"Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c","volume":"32","author":"S Wilson","year":"2014","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/vr.101509","article-title":"Vaccination of dogs with Duramune DAPPi + LC protects against pathogenic canine parvovirus type 2c challenge","volume":"172","author":"S Wilson","year":"2013","journal-title":"Vet Rec"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/s0264-410x(96)00232-0","article-title":"Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease","volume":"15","author":"T D Yule","year":"1997","journal-title":"Vaccine"},{"key":"ref43","first-page":"125","article-title":"Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c","volume":"31","author":"N Decaro","year":"2008","journal-title":"New Microbiol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1136\/vr.164.19.593","article-title":"Severe parvovirus in a 12-year-old dog that had been repeatedly vaccinated","volume":"164","author":"N Decaro","year":"2009","journal-title":"Vet Rec"},{"key":"ref45","first-page":"239","article-title":"Characterization of a canine parvovirus strain isolated from an adult dog","volume":"24","author":"A Cavalli","year":"2001","journal-title":"New Microbiol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1751-0147-55-64","article-title":"Canine parvovirus type 2c identified from an outbreak of severe gastroenteritis in a litter in Sweden","volume":"55","author":"D Sutton","year":"2013","journal-title":"Acta Vet Scand"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/vr.103508","article-title":"Canine parvovirus in vaccinated dogs: A field study","volume":"178","author":"C Miranda","year":"2016","journal-title":"Vet Rec"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.meegid.2014.01.015","article-title":"Molecular typing of canine parvovirus strains circulating from 2008 to 2012 in an organized kennel in India reveals the possibility of vaccination failure","volume":"23","author":"M Mittal","year":"2014","journal-title":"Infect Genet Evol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s00705-019-04198-w","article-title":"New variants of canine parvovirus in dogs in southern Brazil","volume":"164","author":"P SB De Oliveira","year":"2019","journal-title":"Arch Virol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cvsm.2019.02.006","article-title":"Feline Panleukopenia: A Re-emergent Disease","volume":"49","author":"V R Barrs","year":"2019","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jcpa.2007.04.004","article-title":"The challenges of vaccine responses in early life: Selected examples","volume":"137","author":"C A Siegrist","year":"2007","journal-title":"J Comp Pathol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/vr.159.22.733","article-title":"Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines","volume":"159","author":"J G Bergman","year":"2006","journal-title":"Vet Rec"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2460\/ajvr.1997.58.04.360","article-title":"Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection","volume":"58","author":"L J Larson","year":"1997","journal-title":"Am J Vet Res"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.vetmic.2017.08.019","article-title":"Are vaccine strain, type or administration protocol risk factors for canine parvovirus vaccine failure?","volume":"210","author":"K D Altman","year":"2017","journal-title":"Vet Microbiol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/j.jcpa.2007.04.020","article-title":"Alternative early life vaccination programs for companion animals","volume":"137","author":"H Poulet","year":"2007","journal-title":"J Comp Pathol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/s0264-410x(96)00184-3","article-title":"Immunogenicity of a low-passage, high-titer modified live canine parvovirus vaccine in pups with maternally derived antibodies","volume":"15","author":"C M Hoare","year":"1997","journal-title":"Vaccine"},{"key":"ref61","first-page":"210","article-title":"High-titer canine parvovirus vaccine: Serologic response and challenge-of-immunity study","volume":"91","author":"L J Larson","year":"1996","journal-title":"Vet Med"},{"key":"ref62","first-page":"289","volume-title":"Canine viral vaccines at a turning point \u2013 a personal perspective","author":"L E Carmichael","year":"1999"},{"key":"ref63","first-page":"988","article-title":"Untersuchung der Wirksamkeit von Parvovirusimpfstoffen und der Effektivit\u00e4t zweier Impfschemata","volume":"81","author":"K Friedrich","year":"2000","journal-title":"Prakt Tierarzt"},{"key":"ref64","first-page":"1163","volume-title":"Immunoprophylaxis","author":"C E Greene","year":"2012","edition":"4th ed."},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2460\/javma.1994.204.08.1207","article-title":"Serologic response of pups to the low-passage, modified-live canine parvovirus-2 component in a combination vaccine","volume":"204","author":"S E O\u2019Brien","year":"1994","journal-title":"J Am Vet Med Assoc"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/vr.128.16.377","article-title":"Performance of high titre attenuated canine parvovirus vaccine in pups with maternally derived antibody","volume":"128","author":"S Burtonboy","year":"1991","journal-title":"Vet Rec"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.vetmic.2010.11.004","article-title":"Efficacy of vaccination at 4 and 6 weeks in the control of canine parvovirus","volume":"149","author":"K G De Cramer","year":"2011","journal-title":"Vet Microbiol"},{"key":"ref68","first-page":"29","article-title":"Performance of a new generation canine parvovirus vaccine in Rottweiler puppies","volume":"22","author":"J D Hoskins","year":"1997","journal-title":"Canine Pract"},{"key":"ref69","first-page":"22","article-title":"Closing the window of susceptibility","volume":"7","author":"L J Larson","year":"1996","journal-title":"Top Vet Med"},{"key":"ref70","first-page":"640","article-title":"The new generation of parvovirus vaccines. A comparison study","volume":"18","author":"R D Schultz","year":"1996","journal-title":"Compend Contin Educ Vet"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jcpa.2009.10.009","article-title":"Age and long-term protective immunity in dogs and cats","volume":"142","author":"R D Schultz","year":"2010","journal-title":"J Comp Pathol"},{"key":"ref72","first-page":"309","volume-title":"Forty years of canine vaccination","author":"M JG Appel","year":"1999"},{"key":"ref73","first-page":"2769","article-title":"Comparison of quantitative PCR and conventional endpoint PCR for amplication of parvovirus DNA in blood from naturally infected and recently vaccinated dogs. ACVIM Forum & Canadian Veterinary Veterinary Medical Association Convention. Montr\u00e9al, Qu\u00e9bec, Kanada; 2009","volume":"2023","author":"J K Veir","year":"2009","journal-title":"J Vet Intern Med"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tvjl.2016.11.011","article-title":"Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs","volume":"219","author":"M Freisl","year":"2017","journal-title":"Vet J"},{"key":"ref75","first-page":"233","volume-title":"Vaccination","author":"M J Day","year":"2014","edition":"2nd ed."},{"key":"ref76","first-page":"1596","article-title":"New technologies for making vaccines","volume":"17","author":"R W Ellis","year":"1999","journal-title":"Vaccine"},{"key":"ref77","first-page":"79","volume-title":"Antiviral immunity and virus vaccines","author":"N J MacLachlan","year":"2017","edition":"5th ed."},{"key":"ref78","first-page":"261","volume-title":"Vaccines and their production","author":"I R Tizard","year":"2018","edition":"10th ed."},{"key":"ref79","first-page":"535","article-title":"Recombinant vaccine technology in veterinary medicine","volume":"31","author":"K R Van Kampen","year":"2001","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref81","first-page":"408","article-title":"A modified live canine parvovirus strain with novel plaque characteristics. I. Viral attenuation and dog response","volume":"71","author":"L E Carmichael","year":"1981","journal-title":"Cornell Vet"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0042-6822(88)90500-4","article-title":"Canine host range and a specific epitope map along with variant sequences in the capsid protein gene of canine parvovirus and related feline, mink, and raccoon parvoviruses","volume":"166","author":"C R Parrish","year":"1988","journal-title":"Virology"},{"key":"ref85","first-page":"58","article-title":"The immune system and disease resistance","volume":"17","author":"W J Dodds","year":"2002","journal-title":"Clin Tech in Small Anim Pract"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2460\/javma.1990.196.11.1851","article-title":"Risks associated with use of live vaccines","volume":"196","author":"I Tizard","year":"1990","journal-title":"J Am Vet Med Assoc"},{"key":"ref88","first-page":"24","volume-title":"Herstellung und Pr\u00fcfung von Impfstoffen","author":"M Schwanig","year":"2005","edition":"6. Aufl."},{"key":"ref89","first-page":"681","volume-title":"Mechanistic bases for adverse vaccine reactions and vaccine failures","author":"J A Roth","year":"1999"},{"key":"ref90","first-page":"260","volume-title":"Classical attenuated vaccines","author":"J T Van Oirschot","year":"1997"},{"key":"ref91","first-page":"176","volume-title":"Conception of a vaccine","author":"P Desmettre","year":"1997"},{"key":"ref92","first-page":"135","volume-title":"Applications of vaccines","author":"M C Horzinek","year":"1997"},{"key":"ref93","first-page":"9","volume-title":"Immunit\u00e4t und Schutzimpfungen","author":"H W Kreth","year":"2005","edition":"6. Aufl."},{"volume-title":"Duration of immunity to canine vaccines: What we know and don\u2019t know","year":"1999","author":"R D Schultz","key":"ref94"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.vetmic.2006.04.013","article-title":"Duration of immunity for canine and feline vaccines: A review","volume":"117","author":"R D Schultz","year":"2006","journal-title":"Vet Microbiol"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/BF03548083","article-title":"Canine parvovirus infection, canine distemper and infectious canine hepatitis: Inclination to vaccinate and antibody response in the Swedish dog population","volume":"37","author":"P Olson","year":"1996","journal-title":"Acta Vet Scand"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/jsap.12775","article-title":"Long-lived immunity to canine core vaccine antigens in UK dogs as assessed by an in-practice test kit","volume":"59","author":"R Killey","year":"2018","journal-title":"J Small Anim Pract"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/s0195-5616(01)50601-4","article-title":"Vaccines and vaccinations. The strategic issues","volume":"31","author":"R B Ford","year":"2001","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/s0195-5616(01)50603-8","article-title":"Canine vaccination","volume":"31","author":"C E Greene","year":"2001","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref100","first-page":"132","volume-title":"Categories of vaccines","author":"M C Horzinek","year":"1997"},{"key":"ref101","first-page":"574","volume-title":"Adverse effects of vaccination","author":"S Martinod","year":"1997"},{"key":"ref102","first-page":"546","volume-title":"Risks of vaccination","author":"R C Povey","year":"1997"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0195-5616(01)50604-X","article-title":"Vaccine-associated adverse events","volume":"31","author":"E K Meyer","year":"2001","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref104","first-page":"137","article-title":"Canine parvovirus infection potentiates canine distemper encephalitis attributable to modified live-virus vaccine","volume":"180","author":"S Krakowka","year":"1982","journal-title":"J Am Vet Med Assoc"},{"key":"ref105","first-page":"285","article-title":"Use of monoclonal antibodies to confirm vaccine-induced rabies in ten dogs, two cats, and one fox","volume":"185","author":"C A Whetstone","year":"1984","journal-title":"J Am Vet Med Assoc"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/vr.122.3.54","article-title":"Encephalitis in dogs associated with a batch of canine distemper (Rockborn) vaccine","volume":"122","author":"H J Cornwell","year":"1988","journal-title":"Vet Rec"},{"key":"ref107","first-page":"1397","article-title":"Distemper vaccines recalled","volume":"207","author":"J Gloyd","year":"1995","journal-title":"J Am Vet Med Assoc"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/vaccines8030547","article-title":"Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane","volume":"8","author":"M Bergmann","year":"2020","journal-title":"Vaccines"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.vaccine.2006.10.020","article-title":"Occurrence of severe gastroenteritis in pups after canine parvovirus vaccine administration: A clinical and laboratory diagnostic dilemma","volume":"25","author":"N Decaro","year":"2007","journal-title":"Vaccine"},{"key":"ref111","first-page":"1197","article-title":"Sudden death in young dogs with myocarditis caused by parvovirus","volume":"174","author":"M A Hayes","year":"1979","journal-title":"J Am Vet Med Assoc"},{"key":"ref112","first-page":"540","volume-title":"Factors influencing the outcome of vaccination","author":"R C Povey","year":"1997"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0195-5616(01)50608-7","article-title":"What you can and cannot learn from reading a vaccine label","volume":"31","author":"D R Hustead","year":"2001","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref114","first-page":"1170","article-title":"Response of gray foxes to modified live-virus canine distemper vaccines","volume":"179","author":"R D Halbrooks","year":"1981","journal-title":"J Am Vet Med Assoc"},{"key":"ref115","first-page":"203","article-title":"Vaccine-associated canine distemper infection in a litter of African hunting dogs (Lycaon pictus)","volume":"37","author":"B Durchfeld","year":"1990","journal-title":"Zentralbl Veterinaermed B"},{"key":"ref116","first-page":"961","article-title":"Fatal vaccine-induced canine distemper virus infection in black-footed ferrets","volume":"169","author":"J W Carpenter","year":"1976","journal-title":"J Am Vet Med Assoc"},{"key":"ref117","first-page":"1166","article-title":"Vaccination-induced distemper in kinkajous","volume":"179","author":"K R Kazacos","year":"1981","journal-title":"J Am Vet Med Assoc"},{"key":"ref118","first-page":"959","article-title":"Vaccine-induced canine distemper in a lesser panda","volume":"169","author":"M Bush","year":"1976","journal-title":"J Am Vet Med Assoc"},{"key":"ref119","first-page":"371","article-title":"Intranasal vaccination of pups in the presence of maternally derived antibodies to canine parvovirus (CPV). Evaluation of minimal immunizing dose","volume":"18","author":"C Buonavoglia","year":"1995","journal-title":"New Microbiol"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.vaccine.2019.10.016","article-title":"Oral administration of modified live canine parvovirus type 2b induces systemic immune response","volume":"38","author":"A Cavalli","year":"2020","journal-title":"Vaccine"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1128\/cdli.12.10.1243-1245.2005","article-title":"Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies","volume":"12","author":"V Martella","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref122","first-page":"99","article-title":"Response of puppies to canine-origin parvovirus vaccines","volume":"65","author":"L E Carmichael","year":"1984","journal-title":"Mod Vet Practic"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1016\/j.vaccine.2014.04.050","article-title":"Long-term viremia and fecal shedding in pups after modified-live canine parvovirus vaccination","volume":"32","author":"N Decaro","year":"2014","journal-title":"Vaccine"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cvsm.2010.07.007","article-title":"Canine parvovirus","volume":"40","author":"A Goddard","year":"2010","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref125","first-page":"219","article-title":"Canine parvovirus. Part II. Clinical signs, diagnosis, and treatment","volume":"19","author":"D K Macintire","year":"1997","journal-title":"Compend Contin Educ Vet"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1534-6935.2004.04020.x","article-title":"Canine parvoviral enteritis: A review of diagnosis, management, and prevention","volume":"14","author":"J Prittie","year":"2004","journal-title":"J Vet Emerg Crit Care"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/B978\u20131-4377\u20130795\u20133.00014\u20134","volume-title":"Canine parvovirus infections and other viral enteritides","author":"J E Sykes","year":"2014","edition":"1st ed."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/B978\u20131-4377\u20130795\u20133.00012\u20130","volume-title":"Immunization","author":"J E Sykes","year":"2014","edition":"1st ed."},{"key":"ref129","first-page":"67","volume-title":"Canine viral enteritis","author":"C E Greene","year":"2012","edition":"4th ed."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2460\/javma.230.3.359","article-title":"Effect of vaccination on parvovirus antigen testing in kittens","volume":"230","author":"E V Patterson","year":"2007","journal-title":"J Am Vet Med Assoc"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0195-5616(83)50059-4","article-title":"Canine viral enteritis","volume":"13","author":"R V Pollock","year":"1983","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0195-5616(93)50305-4","article-title":"Canine parvovirus","volume":"23","author":"R V Pollock","year":"1993","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1136\/vr.130.2.27","article-title":"Distemper encephalitis in pups after vaccination of the dam","volume":"130","author":"I A McCandlish","year":"1992","journal-title":"Vet Rec"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1099\/0022-1317-79-5-1153","article-title":"No evidence for a role of modified live virus vaccines in the emergence of canine parvovirus","volume":"79","author":"U Truyen","year":"1998","journal-title":"J Gen Virol"},{"key":"ref135","first-page":"274","volume-title":"The use of vaccines","author":"I R Tizard","year":"2018","edition":"10th ed."},{"key":"ref136","first-page":"2020","article-title":"Studies on canine parvovirus infections: Development of an inactivated vaccine","volume":"41","author":"A K Eugster","year":"1980","journal-title":"Am J Vet Res"},{"key":"ref137","first-page":"16","article-title":"Dog response to inactivated canine parvovirus and feline panleukopenia virus vaccines","volume":"72","author":"R V Pollock","year":"1982","journal-title":"Cornell Vet"},{"key":"ref138","first-page":"245","article-title":"The duration of immunity to an inactivated adjuvanted canine parvovirus vaccine. A 52 and 64 week postvaccination challenge study","volume":"24","author":"R C Povey","year":"1983","journal-title":"Can Vet J"},{"key":"ref139","first-page":"14","article-title":"An inactivated canine parvovirus vaccine: Duration of immunity and effectiveness in presence of maternal antibody","volume":"12","author":"B L Wallace","year":"1985","journal-title":"Canine Pract"}],"container-title":["Tier\u00e4rztliche Praxis Ausgabe K: Kleintiere \/ Heimtiere"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1402-9476.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T13:31:47Z","timestamp":1724938307000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1402-9476"}},"subtitle":["Teil 2: Impfstoffe"],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":125,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2021,4,26]]},"published-print":{"date-parts":[[2021,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1402-9476","relation":{},"ISSN":["1434-1239","2567-5842"],"issn-type":[{"type":"print","value":"1434-1239"},{"type":"electronic","value":"2567-5842"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}